Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients

John H Powers 3rd¹, Elizabeth D Bacci², M Lourdes Guerrero³, Nancy Kline Leidy⁴, Sonja Stringer⁴, Katherine Kim⁴, Matthew J Memoli⁵, Alison Han⁵, Mary P Fairchok⁶, Wei-Ju Chen⁷, John C Arnold⁸, Patrick J Danaher⁹, Tahaniyat Lalani¹⁰, Michelande Ridoré¹¹, Timothy H Burgess¹², Eugene V Millar⁷, Andrés Hernández¹³, Patricia Rodríguez-Zulueta¹⁴, Mary C Smolskis⁴, Hilda Ortega-Gallegos³, Sarah Pett¹⁵, William Fischer¹⁶, Daniel Gillor¹⁷, Laura Moreno Macias¹⁸, Anna DuVal¹⁹, Richard Rothman¹⁹, Andrea Dugas¹⁹, Guillermo M Ruiz-Palacios³

Affiliations

¹ Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., NCI Campus at Frederick, Frederick, MD, USA. Electronic address: john.powers@nih.gov.
² Evidera, Seattle, WA, USA.
³ Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
⁴ Evidera, Bethesda, MD, USA.
⁵ National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
⁶ Madigan Army Medical Center, Fort Lewis, WA, USA; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.
⁷ Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.
⁸ Naval Medical Center, San Diego, CA, USA.
⁹ Defense Institute for Medical Operations, San Antonio, TX, USA.
¹⁰ Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA; Naval Medical Center, Portsmouth, VA, USA.
¹¹ Children's National Medical Center, Washington, DC, USA.
¹² Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA; Walter Reed National Military Medical Center, Bethesda, MD, USA.
¹³ Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
¹⁴ Hospital General Dr. Manuel Gea González, Mexico City, Mexico.
¹⁵ University College London, London, UK; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
¹⁶ University of North Carolina, Chapel Hill, NC, USA.
¹⁷ Cologne, Germany.
¹⁸ Hospital General de Agudos JM Ramos Mejia, Buenos Aires, Argentina.
¹⁹ Johns Hopkins University School of Medicine, Baltimore, MD, USA (for the INSIGHT Flu 002 Plus Writing Group, the México Emerging Infectious Diseases Clinical Research Network, and the Infectious Diseases Clinical Research Program).

PMID: 29477403
PMCID: PMC5831548
DOI: 10.1016/j.jval.2017.04.014

Observational Study

Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients

John H Powers 3rd et al. Value Health. 2018 Feb.

. 2018 Feb;21(2):210-218.

doi: 10.1016/j.jval.2017.04.014. Epub 2017 Jun 7.

Authors

Affiliations

¹ Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., NCI Campus at Frederick, Frederick, MD, USA. Electronic address: john.powers@nih.gov.
² Evidera, Seattle, WA, USA.
³ Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
⁴ Evidera, Bethesda, MD, USA.
⁵ National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
⁶ Madigan Army Medical Center, Fort Lewis, WA, USA; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.
⁷ Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.
⁸ Naval Medical Center, San Diego, CA, USA.
⁹ Defense Institute for Medical Operations, San Antonio, TX, USA.
¹⁰ Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA; Naval Medical Center, Portsmouth, VA, USA.
¹¹ Children's National Medical Center, Washington, DC, USA.
¹² Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA; Walter Reed National Military Medical Center, Bethesda, MD, USA.
¹³ Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
¹⁴ Hospital General Dr. Manuel Gea González, Mexico City, Mexico.
¹⁵ University College London, London, UK; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
¹⁶ University of North Carolina, Chapel Hill, NC, USA.
¹⁷ Cologne, Germany.
¹⁸ Hospital General de Agudos JM Ramos Mejia, Buenos Aires, Argentina.
¹⁹ Johns Hopkins University School of Medicine, Baltimore, MD, USA (for the INSIGHT Flu 002 Plus Writing Group, the México Emerging Infectious Diseases Clinical Research Network, and the Infectious Diseases Clinical Research Program).

PMID: 29477403
PMCID: PMC5831548
DOI: 10.1016/j.jval.2017.04.014

Abstract

Objectives: To assess the reliability, validity, and responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) scores for quantifying the presence and severity of influenza symptoms.

Methods: An observational prospective cohort study of adults (≥18 years) with influenza-like illness in the United States, the United Kingdom, Mexico, and South America was conducted. Participants completed the 37-item draft FLU-PRO daily for up to 14 days. Item-level and factor analyses were used to remove items and determine factor structure. Reliability of the final tool was estimated using Cronbach α and intraclass correlation coefficients (2-day reliability). Convergent and known-groups validity and responsiveness were assessed using global assessments of influenza severity and return to usual health.

Results: Of the 536 patients enrolled, 221 influenza-positive subjects comprised the analytical sample. The mean age of the patients was 40.7 years, 60.2% were women, and 59.7% were white. The final 32-item measure has six factors/domains (nose, throat, eyes, chest/respiratory, gastrointestinal, and body/systemic), with a higher order factor representing symptom severity overall (comparative fit index = 0.92; root mean square error of approximation = 0.06). Cronbach α was high (total = 0.92; domain range = 0.71-0.87); test-retest reliability (intraclass correlation coefficient, day 1-day 2) was 0.83 for total scores and 0.57 to 0.79 for domains. Day 1 FLU-PRO domain and total scores were moderately to highly correlated (≥0.30) with Patient Global Rating of Flu Severity (except nose and throat). Consistent with known-groups validity, scores differentiated severity groups on the basis of global rating (total: F = 57.2, P < 0.001; domains: F = 8.9-67.5, P < 0.001). Subjects reporting return to usual health showed significantly greater (P < 0.05) FLU-PRO score improvement by day 7 than did those who did not, suggesting score responsiveness.

Conclusions: Results suggest that FLU-PRO scores are reliable, valid, and responsive to change in influenza-positive adults.

Keywords: influenza; patient-reported outcome; psychometric; reliability; responsiveness; validity.

PubMed Disclaimer

Figures

**Figure 1. Final FLU-PRO Conceptual Framework**

**Figure 2. FLU-PRO Domain and Total Score by Diary Days 1 to 14**

See this image and copyright information in PMC

References

1. Centers for Disease Control and Prevention (CDC) Seasonal Influenza (Flu) in the Workplace. [cited 2015 June 1]; Available from: http://www.cdc.gov/niosh/topics/flu/
1. Centers for Disease Control and Prevention (CDC) Seasonal Influenza (Flu) [cited 2016 January 28]; Available from: http://www.cdc.gov/flu/about/disease/index.htm.
1. Centers for Disease Control and Prevention (CDC) Key Facts about Influenza (Flu) & Flu Vaccine. [cited 2016 January 28]; Available from: http://www.cdc.gov/flu/keyfacts.htm.
1. World Health Organization (WHO) Influenza (Seasonal): Fact sheet N°211. [cited 2015 June 1];2014 Available from: http://www.who.int/mediacentre/factsheets/fs211/en/
1. Osborne R, et al. Measurement of rapid changes in health outcomes in people with influenza symptoms. J Outcomes Res. 2000;4:15–30.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients

Affiliations

Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients

Authors

Affiliations

Abstract

Figures

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical